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Abstract
Background: Kikuchi-Fujimoto’s disease (KFD), also called histiocytic necrotizing lymphadenitis, is a rare, idiopathic
and self-limited condition usually characterized by cervical lymphadenopathy and fever, most often affecting young
patients. Aetiology is unknown. Differential diagnosis includes mainly malignant lymphoma, tuberculous
lymphadenitis and systemic lupus erythematosus (SLE), so early diagnosis is crucial. Pleuropulmonary involvement
due to isolated KFD has been seldom reported.
Case Presentation: a 32-year-old man, on treatment for iatrogenic hypothyroidism, was admitted due to high
grade fever and painful cervical lymphadenopathies. KFD was diagnosed by lymph node biopsy. Some days after
admission the patient got worse, he developed generalized lymphadenopathy, bilateral pleural effusion and
interstitial lung disease. All of them resolved with prednisone and after two years of following up he remains
asymptomatic and without evidence of any other associated disease.
Conclusion: Pleural effusion and interstitial lung disease are very uncommon manifestations of KFD. In our
experience, treatment with oral prednisone was effective.
Background
Kikuchi-Fujimoto’s disease (KFD), or histiocytic necro-
tizing lymphadenitis, was first described in Japan in
1972 as a self-limiting disease mostly affecting the cervi-
cal lymph nodes of young individuals, mainly females
[1]. In 1982 the first cases of KFD were reported in
North America and Europe [2] and the disease is now
reported worldwide. Although the aetiology is unknown,
it has been suggested to be an apoptotic process
mediated mainly by CD8-positive T lymphocytes, and
viral or autoimmune factors are believed to be involved
[1,3]. Occasionally it may be associated with autoim-
mune disease, mostly systemic lupus erythematosus
(SLE) [3,4]. Enlargement of cervical lymph nodes, fever
and leukopenia are the most prominent symptoms,
although several other clinical manifestations have been
reported [1,3]. The authors report the first case of iso-
lated KFD with interstitial lung disease and bilateral
pleural effusion, which also improved quickly with oral
prednisone.
Case Report
A 32-year-old Caucasian man, with a history of
hyperthyroidism six months previous due to toxic multi-
nodular goiter, treated with radioactive iodine, who
developed iatrogenic hypothyroidism and on initiation
of substitutive treatment, was admitted due to persistent
fever (39-40°C), malaise and painful cervical lymphade-
nopathies that had been present for two weeks. Labora-
tory findings were as follows: haematocrit 34%,
haemoglobin 12 g/dl, leukocyte count 3400/mm3 (neu-
trophils 88.2%, lymphocytes 8.7%, monocytes 2.8%), pla-
telet count 246000/mm3, erythrocyte sedimentation rate
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(ALT) 176 IU/L (0-40 IU/L), aspartate aminotransferase
(AST) 89 IU/L (0-40 IU/L), alkaline phosphatase (AlkP)
176 IU/L (40-129 IU/L) and gamma-glutamyl transpep-
tidase (GGT) 657 IU/L (10-50 IU/L); serum lactic dehy-
drogenase (LDH) 1896 IU/L (240-480 IU/L), thyroid-
stimulating hormone (TSH) 73 μIU/ml (0.27-4.2 μIU/
ml) and thyroxine (T4) 0,25 ng/dl (NR:0.93-1.71). Blood
cultures and serologic tests were found to be negative
for human immunodeficiency virus (HIV), hepatitis B
virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus
(EBV), cytomegalovirus (CMV), herpes simplex virus
(HSV), Rubella, Toxoplasma, parvovirus B19, Yersinia
enterocolitica, Salmonella and Brucella. Serum antinuc-
lear antibody (ANA) and rheumatoid factor were also
negative. On admission, chest X-ray was clear in both
lung fields and computed tomography of the neck,
thorax and abdomen revealed only lymphadenopathy
affecting bilateral cervical and one mediastinal lymph
nodes (Figure 1). Cervical lymph node surgical biopsy
was performed on the second day after admission. On
macroscopic examination it appeared homogeneous, of
medium consistency, dark grey colour and 2 × 1.2 × 1.1
cm in size. The patient’s condition worsened over the
following days, with high-grade daily fever, increasing
size of cervical lymph nodes, the development of axillary
lymphadenopathy and mild dyspnoea on exertion, with
decreased breath sounds in both lung bases on physical
examination. A second computed tomography of the
thorax revealed generalized axillary, mediastinal and
hilar lymphadenopathy, interstitial infiltrate in both
lungs and bilateral pleural effusion (Figure 2). Thoraco-
centesis was performed with the following results in
pleural fluid: pH 7.39 (6.8-7.6), glucose 102 mg/dl
(60-100), proteins 3.2 g/dl (0-3), LDH 1694 IU/L (0-
200), 50 leukocytes/ml (0-300); stains and cultures for
bacteria and mycobacteria were negative and malignant
cells were not found on cytologic examination. Cervical
lymph node biopsy revealed necrotizing lymphadenitis
with prominent areas of cortical and paracortical necro-
sis and distortion of the nodal architecture (Figure 3),
Figure 1 On admission both lung fields were clear and one
isolated mediastinal lymph node was observed.
Figure 2 Some days after admission the patient got worse;
and bilateral pleural effusion, interstitial infiltrate in both
lungs, and mediastinal and hilar lymphadenopathy developed.
Figure 3 Peripheral part of the lymph node with cortical and
paracortical necrosis, associated with distortion of normal
nodal architecture. Hematoxylin and eosin staining; magnification
×10.
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numbers of various types of histiocytes at the margins
of the necrotic areas, performing phagocytosis of cellular
debris. Stimulated lymphocytes and immunoblasts were
observed around these areas, along with reduced num-
bers of plasma cells and no neutrophils (Figure 4). Lym-
phoma cells were absent and stains and tissue cultures
for bacteria, fungi and mycobacteria were negative. Pre-
dnisone therapy was started on the 7
th day (after receiv-
ing negative viral results) at a dose of 1 mg/kg/day, with
rapid improvement: the patient became afebrile on day
10, cervical and axillary swelling and tenderness began
to decrease, dyspnoea disappeared and respiratory aus-
cultation normalized. The daily dose of thyroxine was
slowly increased by the endocrinologist. Prior to dis-
charge, chest X-ray was normal. Tapering doses of pre-
dnisone were prescribed throughout the subsequent two
months; all biochemical and haematological parameters
normalized except for TSH, which reached normal
values four months later. After two years of follow-up
appointments the patient remains asymptomatic, physi-
cal examination and chest X-ray are absolutely normal
and serum antinuclear antibodies remain negative.
Discussion
KFD is a benign disease that usually resolves sponta-
neously within one to four months, affects all ethnic
groups and is more common in young women (4:1
female:male ratio), manifests as localized lymphadenopa-
thy, usually in the cervical region, and is commonly
associated with fever and leukopenia [1,5]. The aetiology
of KFD remains obscure: a viral pathogenesis is thought
to be the most likely candidate due to its self-limiting
clinical course and the lack of neutrophilic response
[4,6]. It has been reported in association with Epstein-
Barr virus, human herpesvirus, human herpesvirus 8,
HIV, HTLV1, dengue virus, parvovirus B19, Yersinia
enterocolítica, Bartonella, Brucella, Entamoeba histoly-
tica and Toxoplasma [7,8]. On the other hand, an auto-
immune origin has also been suggested due to electron
microscopic studies that have identified tubular reticular
structures in the cytoplasm of stimulated lymphocytes
and histiocytes in patients with KFD, which have also
been noted within lymphocytes and endothelial cells of
patients with systemic lupus erythematosus and other
autoimmune disorders, so it is possible that KFD may
represent an exuberant T-cell-mediated, self-limited
immune response to a variety of non-specific stimuli in
genetically susceptible individuals [9].
The differential diagnosis of lymph node enlargement
in patients with the clinical signs of KFD includes
mainly tuberculous and other infectious types of lym-
phadenitis, and malignant lymphoma [4]. The diagnosis
is confirmed by lymph node biopsy, when histopathol-
ogy reveals necrotizing lymphadenitis restricted to the
cortical and paracortical areas, with partial or complete
loss of follicular architecture, marked karyorrhexis and
absence of neutrophils, granulomatous reaction or lym-
phoma cells [5]. Most KFD cases improve within a six-
month period [3], and a wide range of recurrence rates
have been reported, from 4% to 27% [10-12].
Kikuchi-Fujimoto disease has occasionally been
described in association with simultaneous SLE [4,5],
Sjögren syndrome [13], antiphospholipid syndrome
[4,14], relapsing polychondritis [15] or even autoim-
mune hepatitis [16]. On the other hand, unusual mani-
festations of isolated KFD include axillary and
mesenteric lymphadenopathy, splenomegaly, parotid
gland enlargement, skin rashes, arthralgias, myalgias,
aseptic meningitis, bone marrow haemophagocytosis
and liver dysfunction [3]. Patients with arthritis [17,18]
or bilateral panuveitis [19] have been reported on occa-
sion. KFD has seldom been reported in association with
pulmonary involvement [20] and most such cases have
been in patients who developed SLE [4]. Wilkinson et
al. described a 41-yr-old lady diagnosed with KFD who
subsequently developed polymyositis with pulmonary
involvement [21]. Meanwhile, Kucukardali et al.
reported one case of fatal pulmonary haemorrhage due
to KFD upon post-mortem examination and three cases
w h od e v e l o p e dK F Da f t e rt r ansplantation and died of
respiratory failure [3]. Fin a l l y ,o n ec a s eo fK F Da s s o -
ciated with cryptogenic organizing pneumonia has been
reported recently [22]. In the present case, the patient
developed isolated KFD with pleuropulmonary involve-
ment due to interstitial lung infiltrate and pleural effu-
sion, both bilateral and with rapid improvement and
resolution with oral prednisone. The simultaneous
hypothyroidism of the patient should not be ignored,
Figure 4 Non-neutrophilic karyorrhexis.H i s t i o c y t e sa n d
plasmacytoid monocytes performing phagocytosis of cellular debris.
Hematoxylin and eosin staining; magnification × 60.
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sence several months before the development of KFD
and even after the clinical and analytical resolution of
the latter, combined with the absence of any other clini-
cal symptoms related to thyroxine defficiency and the
rapid development and improvement of the pleuropul-
monary manifestations with prednisone, suggest an
inflammatory rather than an endocrine aetiology.
In conclusion, pleuropulmonary involvement in
patients with KFD has seldom been reported. We
describe a patient with isolated KFD in whom bilateral
pleural effusion and an interstitial lung pattern devel-
oped. Clinical and radiological responses to prednisone
were excellent.
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